| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/08/1989 | WO1989007940A1 1,2-hydroxy phosphonates and derivatives thereof |
| 09/08/1989 | WO1989007144A3 High yield protein production system |
| 09/07/1989 | DE3905865A1 Bacillus thuringiensis gene und toxine Bacillus thuringiensis genes and toxins |
| 09/07/1989 | DE3904303A1 Structural phosphoprotein (pp28) of human cytomegalovirus (HCMV), its preparation and use |
| 09/06/1989 | EP0331640A2 Use of an interleukin-6 molecule in inhibiting bone resorption |
| 09/06/1989 | EP0331609A2 Angiotensin converting enzyme inhibitors having psychotropic effects |
| 09/06/1989 | EP0331514A2 Assaying the duchenne muscular dystrophy protein deletion or defect |
| 09/06/1989 | EP0331470A2 Novel hybrid bacillus thuringiensis gene, plasmid, and transformed pseudomonas fluorescens |
| 09/06/1989 | EP0331356A2 Expression of HIV binding proteins |
| 09/06/1989 | EP0331186A2 Monoclonal antibody selectively binding to novel g-csf derivative |
| 09/06/1989 | EP0331184A2 Peptide equivalents of non-peptides and methods of design therefor |
| 09/06/1989 | EP0331105A2 1,2-Hydroxy phosphonates and derivatives thereof |
| 09/06/1989 | EP0331100A1 Anti-endothelin antibodies and their use |
| 09/06/1989 | EP0331088A2 Remedy for hematopoietic tissue diseases comprising human monocytic macrophage colony stimulating factor as active ingredient |
| 09/06/1989 | EP0331073A2 Benzhydrylamine derivatives |
| 09/06/1989 | EP0330977A2 Production of recombinant eucaryotic cells capable of a high expression |
| 09/06/1989 | EP0330925A2 Renin-inhibiting amino acid derivatives |
| 09/06/1989 | EP0330878A2 Anti-ras protein-antibodies |
| 09/06/1989 | EP0330801A1 Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
| 09/06/1989 | EP0330781A1 Vaccine against rinderpest virus using recombinant vaccinia virus |
| 09/06/1989 | EP0330725A1 Preparation and expression of DNA sequences coding for proteins having the biological properties of cystatin C |
| 09/06/1989 | EP0330696A1 Recombinant antibodies and methods for their production |
| 09/06/1989 | EP0330681A1 Vaccines against animal parasitic nematodes |
| 09/06/1989 | CN1035320A Acylamino acid racemase and its use |
| 09/05/1989 | US4864019 Antibodies to inhibin and conjugates produced therefrom |
| 09/05/1989 | US4863903 Substituted 5-amino-4-hydroxyvaleryl derivatives |
| 09/05/1989 | US4863899 Biologically active polypeptides |
| 09/05/1989 | US4863857 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known |
| 09/05/1989 | US4863854 Monoclonal antibodies to mucin-like human differentiation antigens |
| 09/05/1989 | US4863850 Method for diagnosis of rheumatoid arthritis |
| 09/05/1989 | US4863732 Injectable composition for inductive bone repair |
| 09/05/1989 | US4863728 Monoclonal anti-alpha-amylase antibody which non-specifically inhibits the enzyme activity of human alpha-amylase |
| 09/05/1989 | US4863609 Process for the fractional separation of protein mixtures by means of membranes |
| 09/04/1989 | EP0316444A4 Yeast expression vector. |
| 08/30/1989 | EP0330647A2 The use of chymotrypsin for the inactivation of prekallikrein activator |
| 08/30/1989 | EP0330521A2 Antihypertensive hyperimmune milk |
| 08/30/1989 | EP0330506A2 VLA proteins |
| 08/30/1989 | EP0330479A2 Plant universal stress-inducible regulatory element |
| 08/30/1989 | EP0330451A2 A cDNA coding for human normal serum albumin a, and a process for production of the albumin |
| 08/30/1989 | EP0330396A2 DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI |
| 08/30/1989 | EP0330389A2 Human collagen processing and autoimplant use |
| 08/30/1989 | EP0330359A2 Composition useful in the diagnosis and treating of HIV-1 infection |
| 08/30/1989 | EP0330342A1 Novel coleopteran-active bacillus thuringiensis isolate |
| 08/30/1989 | EP0330241A2 Calcitonin derivatives |
| 08/30/1989 | EP0330227A2 Derivatives of soluble T-4 |
| 08/30/1989 | EP0330201A2 Method of enhancing the effect of cytotoxic agents |
| 08/30/1989 | EP0330191A2 DNA encoding CD40 |
| 08/30/1989 | EP0330051A1 Human cytomegalovirus structural phosphoprotein (pp28), its preparation and use |
| 08/30/1989 | EP0329994A1 Immunogen and its use in preparing antibodies to haemoglobin A1C |
| 08/30/1989 | EP0329778A1 Molecular decoyants and methods of use thereof |
| 08/30/1989 | EP0329761A1 Hiv-1-related polypeptides, diagnostic systems and assay methods |
| 08/30/1989 | EP0329760A1 Suppressive t lymphocyte cell lines and supernatant derivative thereof |
| 08/30/1989 | EP0329755A1 Recombinant antibody and method |
| 08/30/1989 | EP0329710A1 Microbial production of peptide oligomers |
| 08/30/1989 | EP0329699A1 Immunometric assay for the detection of human chorionic gonadotropin |
| 08/30/1989 | EP0329693A1 Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same |
| 08/30/1989 | EP0329684A1 Composite yeast vectors |
| 08/30/1989 | EP0204788B1 New hypocalcemic polypeptides, preparation thereof and drugs containing these active principles |
| 08/30/1989 | CN1035129A Pyrimidine analogue resistance gene dna and its use |
| 08/30/1989 | CN1035128A Monoclonal antibodies, a method for the preparation thereof and use thereof |
| 08/30/1989 | CN1035126A Gene fragment coding for rabies virus glycoprotein and process for preparing rabies virus glycoprotein using the same |
| 08/29/1989 | US4861869 Coupling agents for joining radionuclide metal ions with biologically useful proteins |
| 08/29/1989 | US4861868 Production of proteins in procaryotes |
| 08/29/1989 | US4861867 Purified hemoglobin solutions and method for making same |
| 08/29/1989 | US4861865 Novel antithrombin peptide |
| 08/29/1989 | US4861864 Rotavirus antigens |
| 08/29/1989 | US4861757 Wound healing and bone regeneration using PDGF and IGF-I |
| 08/29/1989 | US4861756 Synthetic pulmonary surfactant |
| 08/29/1989 | US4861755 Peptides with vasorelaxant, natriuretic and diuretic effects a process for their preparation, agents containing them, and their use |
| 08/29/1989 | US4861720 Oncornavirus vaccines and feline alpha-type interferon |
| 08/29/1989 | US4861710 Recombinant DNA clone encoding laminin receptor |
| 08/29/1989 | US4861707 Polypeptides; aids |
| 08/29/1989 | US4861705 Method for removing components of biological fluids |
| 08/29/1989 | US4861595 Cellular encapsulation of biologicals for animal and human use |
| 08/29/1989 | US4861588 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 08/29/1989 | US4861581 Detection of necrotic malignant tissue and associated therapy |
| 08/29/1989 | US4861383 Process for recovering subterranean stem starch and protein |
| 08/29/1989 | CA1258948A1 Hydroxy substituted peptide compounds |
| 08/24/1989 | WO1989007657A1 Amyloid protein precursors, genetic probes, antibodies, and methods of use |
| 08/24/1989 | WO1989007652A1 Genes and their encoded proteins which regulate gene expression of the interleukin-2 receptor and of human lymphotropic retroviruses |
| 08/24/1989 | WO1989007651A2 Methods for controlling norleucine content in polypeptides |
| 08/24/1989 | WO1989007650A1 Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated response and method of producing the same |
| 08/24/1989 | WO1989007649A1 Immunoglobulin binding substance, subfragments, a process for preparing thereof, reagent kit and immunoglobulin binding organisms |
| 08/24/1989 | WO1989007646A1 T cell activation markers |
| 08/24/1989 | WO1989007645A1 Rhoptry membrane antigen of plasmodium falciparum |
| 08/24/1989 | WO1989007644A1 Pox virus vectors |
| 08/24/1989 | WO1989007615A1 Immunogenic glycoproteins of human cytomegalovirus |
| 08/24/1989 | WO1989007614A1 Nuclear factors associated with transcriptional regulation |
| 08/24/1989 | WO1989007613A1 Proteins which induce immunological effector cell activation and chemattraction |
| 08/24/1989 | WO1989007611A1 Prepromotilin and motilin-associated peptide (map) |
| 08/24/1989 | WO1989007609A1 Homoarginine-based peptides as platelet aggregation inhibitors |
| 08/24/1989 | WO1989007608A1 Blocking, isolating and purifying calcium channels |
| 08/24/1989 | WO1989007605A1 Bacillus thuringiensis var. israelensis cryd toxin gene, protein and related insecticide compositions |
| 08/24/1989 | WO1989007601A1 Antigens against autoimmune diseases |
| 08/24/1989 | WO1989007452A1 Improvements in or relating to antibodies |
| 08/24/1989 | WO1989007451A1 Reduced size lhrh analogs |
| 08/24/1989 | WO1989007448A1 Use of synthetic peptides to generate and manipulate cellular immunity |
| 08/24/1989 | WO1989007136A3 Modified hepatocytes and uses therefor |
| 08/24/1989 | WO1989006974A3 T-cell epitope as carriers molecule for conjugate vaccines |
| 08/23/1989 | EP0329622A2 Method of cleavage at methionine of polypeptides |